Finance

Lists
Why is QURE down 3,32%?
Dive Deeper
QURE:NASDAQ
Uniqure NV
USD 21,84
-3,32%
(-0,75) 1D
USD 21,83
-0,05% (-0,010)
Pre-market
Closed: 12 Okt., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for QURE...
Open
USD 22,38
High
USD 22,59
Low
USD 21,49
Mkt. cap
1,51 mjd
Avg. vol.
2,78 m
Volume
679,00
52-wk high
USD 71,50
52-wk low
USD 8,73
EPS
-USD 4,05
Beta
1,06
Shares outstanding
69,37 m
No. of employees
221
Open
USD 22,38
High
USD 22,59
Low
USD 21,49
Mkt. cap
1,51 mjd
Avg. vol.
2,78 m
Volume
679,00
52-wk high
USD 71,50
52-wk low
USD 8,73
EPS
-USD 4,05
Beta
1,06
Shares outstanding
69,37 m
No. of employees
221
News stories
From web sources and news partners
Profile
uniQure is a Dutch biopharmaceutical company which makes gene therapies. It has developed several adeno-associated virus gene therapies. Wikipedia
About Uniqure NV
CEOMatt Kapusta
Employees221
Founded1998
Headquarters-
Sector-
Analyst ratings
Based on 9 analysts giving stock ratings to QURE in the past 3 months
Strong buy
Buy
7
Hold
2
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for QURE in the last 3 months.
Highest
Current USD 21,84
USD 80,00 (+266,30%)
Average
USD 54,50 (+149,54%)
Lowest
USD 28,00 (+28,21%)
Analyst
Recommendation
Action
Price target
Projected
Date
Eliana Merle
Barclays
Hold
Downgraded
USD 28,00
+28,2%
10/06/2026
Luca Issi
RBC Capital
Buy
Reiterated
USD 48,00
+119,8%
10/02/2026
Salveen Richter
Goldman Sachs
Hold
Reiterated
USD 31,00
+41,9%
09/30/2026
Yanan Zhu
Wells Fargo
Buy
Maintained
USD 75,00
+243,4%
09/29/2026
Patrick Trucchio
H.C. Wainwright
Buy
Reiterated
USD 80,00
+266,3%
09/30/2026
Lachlan Hanbury Brown
William Blair
Buy
Maintained
-
-
09/29/2026
Paul Matteis
Stifel Nicolaus
Buy
Maintained
-
-
09/29/2026
Joseph Thome
TD Cowen
Buy
Maintained
-
-
09/02/2026
Sami Corwin
William Blair
Buy
Initiated
USD 73,00
+234,2%
09/02/2026
Uy Ear
Mizuho Securities
Buy
Reiterated
USD 68,00
+211,4%
07/29/2026
Rudy Li
Wolfe Research
Buy
Upgraded
USD 65,00
+197,6%
07/29/2026
Joseph Schwartz
Leerink Partners
Buy
Reiterated
USD 70,00
+220,5%
06/17/2026
Kristen Kluska
Cantor Fitzgerald
Buy
Upgraded
-
-
06/17/2026
Daniil Gataulin
Chardan Capital
Buy
Reiterated
USD 37,00
+69,4%
05/05/2026
Unknown Analyst
Guggenheim
Buy
Maintained
USD 95,00
+335%
05/05/2026
Last report
29 Jul. 2026
Fiscal period
Q2 2026
-€1,07 / -€0,71
-51,25%miss
Revenue / Est. (EUR)
5,13 m / 4,32 m
+18,66%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
3,70 m
5,57 m
3,56 m
5,84 m
Cost of goods sold
32,25 m
40,18 m
30,73 m
30,66 m
Cost of revenue
32,25 m
40,18 m
30,73 m
30,66 m
Research and development expenses
695,00 k
-5,92 m
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19,44 m
21,61 m
20,07 m
19,77 m
Operating expense
20,67 m
15,55 m
19,89 m
26,13 m
Total operating expenses
52,91 m
55,73 m
50,62 m
56,79 m
Operating income
-49,21 m
-50,16 m
-47,06 m
-50,95 m
Other non operating income
-7,22 m
18,13 m
3,77 m
-15,97 m
EBT including unusual items
-71,90 m
-41,00 m
-53,05 m
-79,22 m
EBT excluding unusual items
-70,08 m
-40,05 m
-54,38 m
-77,96 m
Income tax expense
8,63 m
-3,92 m
488,00 k
1,84 m
Effective tax rate
-12,00%
9,55%
-0,92%
-2,32%
Other operating expenses
534,00 k
-143,00 k
-181,00 k
6,36 m
Net income
-80,53 m
-37,09 m
-53,54 m
-81,06 m
Net profit margin
-2 175,87%
-666,06%
-1 502,95%
-1 387,76%
Earnings per share
-
-
-
-
Interest and investment income
3,50 m
5,81 m
5,23 m
5,05 m
Interest expense
-16,72 m
-14,57 m
-14,03 m
-14,37 m
Net interest expenses
-13,22 m
-8,76 m
-8,80 m
-9,32 m
Depreciation and amortization charges
-
-
-
-
EBITDA
-45,58 m
-47,19 m
-44,10 m
-46,04 m
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google-programme